Meroven Pharma India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -52.59%
- Ebitda -10.00%
- Net Worth -1.10%
- Total Assets 0.03%
About Meroven Pharma India
Meroven Pharma India Private Limited (MPIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 08 August 2016 (Eight years and six months 0 days old ). Its registered office is in New Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Eyad Alsaleh, Abdalla Darvesh, and Alaa Alsaleh serve as directors at the Company.
Company Details
-
Location
New Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299DL2016FTC304106
-
Company No.
304106
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
08 Aug 2016
-
Date of AGM
28 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Meroven Pharma India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Eyad Alsaleh
|
Director | 08-Aug-2016 | Current |
Abdalla Darvesh
|
Additional Director | 10-Apr-2018 | Current |
|
Alaa Alsaleh
|
Director | 08-Aug-2016 | Current |
Financial Performance of Meroven Pharma India.
Meroven Pharma India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 52.59% decrease in profit. The company's net worth dipped by a decrease of 1.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meroven Pharma India?
In 2019, Meroven Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Meroven Pharma India?
Unlock and access historical data on people associated with Meroven Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meroven Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meroven Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
